Show simple item record

dc.contributor.authorSnowsill, TM
dc.date.accessioned2017-02-15T11:58:32Z
dc.date.issued2017-02-15
dc.description.abstractThis is an economic model, developed in Microsoft Excel, for evaluating the cost-effectiveness (cost-utility) of different immunosuppressive regimens for adult kidney transplant recipients. This is the Assessment Group economic evaluation for the National Institute for Health and Care Excellence (NICE) Technology Appraisal guidance in development: Kidney transplantation (adults) - immunosuppressive therapy (review of TA 85) [ID456]. It produces the deterministic base case analysis for the model, and the probabilistic sensitivity analysis (PSA) as reported to NICE and in the monograph [Jones-Hughes T, Snowsill T, Haasova M, et al. Immunosuppressive therapy for kidney transplantation in adults: a systematic review and economic evaluation. Health Technology Assessment 2016;20(62)]. It includes the specific PSA dataset upon which the results were based, but can be used to generate a new PSA dataset.en_GB
dc.identifier.urihttp://hdl.handle.net/10871/25885
dc.language.isoenen_GB
dc.publisherUniversity of Exeteren_GB
dc.relation.urlhttps://doi.org/10.3310/hta20610en_GB
dc.subjectMultiple Technology Assessment (MTA)en_GB
dc.subjectTacrolimusen_GB
dc.subjectSirolimusen_GB
dc.subjectMycophenolate mofetilen_GB
dc.subjectMycophenolate sodiumen_GB
dc.subjectEverolimusen_GB
dc.subjectBelatacepten_GB
dc.subjectBasiliximaben_GB
dc.subjectRabbit anti-thymocyte globulinen_GB
dc.subjectDecision modelen_GB
dc.titleImmunosuppressive therapy for kidney transplantation in adults: Economic model (dataset)en_GB
dc.typeDataseten_GB
dc.date.available2017-01-23en_GB
dc.date.available2017-02-15T11:58:32Z


Files in this item

This item appears in the following Collection(s)

Show simple item record